Detailed Information

Cited 28 time in webofscience Cited 37 time in scopus
Metadata Downloads

Withanone-Rich Combination of Ashwagandha Withanolides Restricts Metastasis and Angiogenesis through hnRNP-K

Full metadata record
DC Field Value Language
dc.contributor.authorGao, Ran-
dc.contributor.authorShah, Navjot-
dc.contributor.authorLee, Jung-Sun-
dc.contributor.authorKatiyar, Shashank P.-
dc.contributor.authorLi, Ling-
dc.contributor.authorOh, Eonju-
dc.contributor.authorSundar, Durai-
dc.contributor.authorYun, Chae-Ok-
dc.contributor.authorWadhwa, Renu-
dc.contributor.authorKaul, Sunil C.-
dc.date.accessioned2021-08-02T18:28:09Z-
dc.date.available2021-08-02T18:28:09Z-
dc.date.created2021-05-12-
dc.date.issued2014-12-
dc.identifier.issn1535-7163-
dc.identifier.urihttps://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/25704-
dc.description.abstractAshwagandha is an important herb used in the Indian system of traditional home medicine, Ayurveda. Alcoholic extract (i-Extract) from its leaves and its component, withanone, were previously shown to possess anticancer activity. In the present study, we developed a combination of withanone and withaferin A, major withanolides in the i-Extract, that retained the selective cancer cell killing activity and found that it also has significant antimigratory, -invasive, and -angiogenic activities, in both in vitro and in vivo assays. Using bioinformatics and biochemical approaches, we demonstrate that these phytochemicals caused downregulation of migration-promoting proteins hnRNP-K, VEGF, and metalloproteases and hence are candidate natural drugs for metastatic cancer therapy. (C)2014 AACR.-
dc.language영어-
dc.language.isoen-
dc.publisherAMER ASSOC CANCER RESEARCH-
dc.titleWithanone-Rich Combination of Ashwagandha Withanolides Restricts Metastasis and Angiogenesis through hnRNP-K-
dc.typeArticle-
dc.contributor.affiliatedAuthorYun, Chae-Ok-
dc.identifier.doi10.1158/1535-7163.MCT-14-0324-
dc.identifier.scopusid2-s2.0-84918562005-
dc.identifier.wosid000346132900015-
dc.identifier.bibliographicCitationMOLECULAR CANCER THERAPEUTICS, v.13, no.12, pp.2930 - 2940-
dc.relation.isPartOfMOLECULAR CANCER THERAPEUTICS-
dc.citation.titleMOLECULAR CANCER THERAPEUTICS-
dc.citation.volume13-
dc.citation.number12-
dc.citation.startPage2930-
dc.citation.endPage2940-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaOncology-
dc.relation.journalWebOfScienceCategoryOncology-
dc.subject.keywordPlusNUCLEAR RIBONUCLEOPROTEIN K-
dc.subject.keywordPlusBREAST-CANCER CELLS-
dc.subject.keywordPlusGROWTH-FACTOR VEGF-
dc.subject.keywordPlusMATRIX METALLOPROTEINASES-
dc.subject.keywordPlusMOLECULAR-DYNAMICS-
dc.subject.keywordPlusENDOTHELIAL-CELLS-
dc.subject.keywordPlusSIGNALING PATHWAY-
dc.subject.keywordPlusLEAF EXTRACT-
dc.subject.keywordPlusWITHAFERIN-
dc.subject.keywordPlusACTIVATION-
Files in This Item
There are no files associated with this item.
Appears in
Collections
서울 공과대학 > 서울 생명공학과 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Yun, Chae Ok photo

Yun, Chae Ok
COLLEGE OF ENGINEERING (DEPARTMENT OF BIOENGINEERING)
Read more

Altmetrics

Total Views & Downloads

BROWSE